===============================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-----------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
September 28, 2000
LABORATORY CORPORATION OF AMERICA HOLDINGS
(Exact Name of Registrant as Specified in Its Charter)
Delaware 1-11353 13-3757370
(State of incorporation (Commission File Number) (I.R.S. Employer
or organization) Identification No.)
358 South Main Street
Burlington, North Carolina 27215
(Address, including zip code of Registrant's principal executive offices)
Registrant's telephone number, including area code: (336) 229-1127
===============================================================================
<PAGE>
Item 5: Other Events
Filed herewith as an exhibit in connection with the Registration Statement
on Form S-3 (Registration No. 333-46776) filed by Laboratory Corporation of
America Holdings (the "Company") with the Securities and Exchange Commission on
September 28, 2000, as amended, is the Underwriting Agreement, dated October
13, 2000, entered into by the Company, Credit Suisse First Boston Corporation,
Merrill Lynch, Pierce, Fenner & Smith Incorporated, and UBS Warburg LLC
(together, the "Underwriters"), and selling stockholders Roche Holdings, Inc.,
Thomas P. MacMahon and Bradford T. Smith (together, the "Selling
Stockholders").
The Registration Statement and the Underwriting Agreement related to the
proposed offer and sale on October 18, 2000 by Roche Holdings, Inc. of
4,000,000 shares of Common Stock, par value $0.10 per share, of the Company
("Common Stock"), and by Thomas P. MacMahon and Bradford T. Smith of 115,000
and 35,000 shares of Common Stock respectively pursuant to options held by
them, resulting in proceeds to the Selling Stockholders of $115.10 per share.
Item 7: Financial Statements, Pro Forma Financial Information and Exhibits
(c) Exhibits
The following exhibit is filed herewith:
1 Underwriting Agreement dated October 13, 2000, between the
Company, the Selling Stockholders, and Credit Suisse First
Boston Corporation as representative for the Underwriters,
relating to the sale of the Common Stock by the Selling
Stockholders on October 18, 2000.
2
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
LABORATORY CORPORATION OF AMERICA
HOLDINGS
By: /s/ Bradford T. Smith
-------------------------------------
Name: Bradford T. Smith
Title: Executive Vice President,
General Counsel, Secretary and
Compliance Officer
Date: October 30, 2000
3
